PACES Exams Management Flashcards
Management of Cystic Fibrosis
Managed under the CF MDT…
Conservative: Chest physiotherapy & education Vaccinations Enzyme replacement Family planning counselling (in males) Medical: ABx prophylaxis: Flucloxacillin Mucolytic: rhDNase or Mannitol dry powder Surgical: Lung transplantation
Complications of Cystic Fibrosis
Recurrent & chronic pulmonary infections:
P.aeruginosa, Burkholderia, Haemophilus, Aspergillus.
Nutritional deficiency (failure to thrive)
Endocrine: Diabetes Mellitus (insulin dependent), Osteoporosis, Infertility
Chronic Management of COPD
Conservative
Smoking cessation
Vaccinations
Pulmonary Rehabilitation (MRC dyspnoea 3+)
Medical
Nebulisers:
1st: a short acting inhaler (SABA or SAMA)
2nd: a) switch to long acting (LABA + LAMA)
b) if asthma/reversible features (LABA + ICS)
3rd: trial of all three (LABA + LAMA + ICS)
If still regular exacerbations/impaired mucus clearance – prophylactic azithromycin
Consider LTOT
Surgical
Lung volume reduction surgery
Indications for LTOT in COPD
Assessed via multiple ABGs PaO2 <7.3 OR PaO2 <8.0 + any of the following: Polycythaemia Pulmonary HTN Peripheral oedema
Note: No LTOT if still smoking
Acute COPD management
Conservative
Titrate oxygen between 88-92% using venturi
Regular ABG monitoring
Medical
Infection: qSOFA and Sepsis 6. Abx therapy
Inflammation:
o SABA – 5mg Salbutamol nebulised
o SAMA – 0.5 micrograms Ipratropium bromide nebulised
o 30mg prednisolone for 5 days + nebulisers
Ventilation: BiPAP -> intubation
Note: common bacterial cause is Haemophilus influenzae.
What classification system is used for COPD?
GOLD classification: Based on FEV1 as a % of predicted value for individual…
20, 30, 20 30 (interval sizes)
Stage 1: >80%
Stage 2: 79-50%
Stage 3: 49-30%
Stage 4: <30%
What are the levels of the MRC dyspnoea scale and what does it describe?
Symptomatic severity of dyspnoea (chronically)
1: Sports
2: Steep hill
3: slower
4: stop after 100m
5: stays at home (breathless on undressing etc.)
What classifcation is used to determine severity in heart failure?
NYHA: I. No symptoms II. Ordinary activity causes dyspnoea III. Sub-ordinary causes dyspnoea IV. Dyspnoea at rest
Note: this is a functional assessment
What is the difference between a Pacemaker and an ICD?
An ICD is an Implanatable cardioverter defibrillator.
ICDs are installed to recognise tachyarrhthymias and shock the patient (without warning).
Pacemakers act as surrogate SANs. They maintain a heartbeat they do not stop it.
What are the types of Pacemaker?
Temporary
Percutaneous (by defibrillator)
Transvenous (by cardio)
Epicardial (by cardiothoracics)
Permanent
Single Chamber (RA or RV)
Dual Chamber (RA + RV)
Biventricular (RA + RV + LV)
What are some indications for Pacing?
Temporary:
Bradycardia unresponsive to Atropine
Post-MI (anterior) complications
Permanent:
Sick Sinus syndrome*
AF
Heart Block (including trifascicular block)
*SAN dysfunction leading to tachy and brady spells
What are some potential complications of Pacemaker insertion?
Immediate
Bleeding
Pneumothorax/haemothorax
Early
Infection: endocarditis & sepsis
Insertion site infection
VTE
Late
Wire displacement (pacing failure)
Device malfunction & Twiddler’s syndrome (fiddling with it)
Management of Pulmonary oedema
Conservative: Sit them upright 15L non rebreathe and titrate <94% Fluid balance review Monitor Weight & renal function
Medical:
Diuretics: Furosemide 40mg IV infusion
Management of Chronic Heart failure
Heart failure treatment is carried out by the MDT including specialist cardiac failure nurses.
Conservative
Monitor exercise tolerance.
Smoking & alcohol cessation
Cardiac rehabilitation: Exercise and weight loss
Vaccination: Annual influenza + one off pneumococcal
Medical
Prognostic benefit: 1st: ACEi + Beta Blocker, 2nd: Spironolactone
Symptom relief: Diuretics
Surgical
Heart transplant
Note: 3rd line is specialist: Entresto is used if <35% Ejection Fraction
Management of Acute Asthma
Conservative
Peak flow + ABG
15L Oxygen via Non-rebreathe mask to maintain >94%
Medical:
1st: 5mg nebulised Salbutamol + 40mg Prednisolone PO for 5 days
2nd: 0.5mg nebulised Ipratropium (4 hourly)
3rd: 2g Mg Sulphate IV (SENIOR)
Diagnostic criteria of asthma in adults
PEF variability >20%
FEV1 >12% / 200ml
FeNO > 40 ppb
Grading of acute asthma severity
Moderate >50%
Severe >33% Tachyp, Tachyc + cannot complete sentence
Life threatening <33% SpO2 <92%, Silent chest, Hypotensive
Near fatal Raised PaCO2
Chronic Asthma management in Adults
Conservative
Personalised Asthma action plan (check inhaler technique)
Trigger avoidance (vacuum cleaning, mattress covers)
Breathing exercise programmes
Weight loss
Medical
1st: SABA + low ICS
2nd: LABA + low ICS
3rd: LABA + low ICS + LTRA
4th: Conversion to MART (+/- LTRA)
5th: MART with Medium ICS dose (+/- LTRA)
6th: MART with High ICS dose or add LAMA or REFER
Note: from 5th step – can continue with MART as shown or revert back to separate drugs i.e. LABA and ICS inhalers.
Management of pulmonary fibrosis
Conservative: Smoking cessation LTOT Pulmonary rehabilitation Medical None Surgical Lung transplantation
Antibiotic therapy of HAP
<5 days of admission = cefuroxime
>5 days of admission = Piperacillin with Tazobactam